A detailed history of Dimensional Fund Advisors LP transactions in Repligen Corp stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 453,572 shares of RGEN stock, worth $56.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
453,572
Previous 429,524 5.6%
Holding current value
$56.6 Million
Previous $54.1 Million 24.67%
% of portfolio
0.02%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$119.79 - $167.35 $2.88 Million - $4.02 Million
24,048 Added 5.6%
453,572 $67.5 Million
Q2 2024

Aug 09, 2024

BUY
$120.0 - $182.95 $14.6 Million - $22.2 Million
121,305 Added 39.36%
429,524 $54.1 Million
Q1 2024

May 10, 2024

BUY
$170.78 - $208.42 $1.07 Million - $1.3 Million
6,251 Added 2.07%
308,219 $56.7 Million
Q4 2023

Feb 07, 2024

BUY
$114.17 - $185.35 $1.88 Million - $3.05 Million
16,430 Added 5.75%
301,968 $54.3 Million
Q3 2023

Nov 09, 2023

BUY
$138.78 - $176.51 $3.51 Million - $4.46 Million
25,282 Added 9.71%
285,538 $45.4 Million
Q2 2023

Aug 09, 2023

BUY
$138.42 - $180.31 $2.72 Million - $3.54 Million
19,633 Added 8.16%
260,256 $36.8 Million
Q1 2023

May 12, 2023

BUY
$154.26 - $198.1 $1.04 Million - $1.34 Million
6,766 Added 2.89%
240,623 $40.5 Million
Q4 2022

Feb 09, 2023

BUY
$162.42 - $220.56 $628,240 - $853,126
3,868 Added 1.68%
233,857 $39.6 Million
Q3 2022

Nov 10, 2022

BUY
$160.42 - $256.21 $246,405 - $393,538
1,536 Added 0.67%
229,989 $43 Million
Q2 2022

Aug 12, 2022

SELL
$140.68 - $188.02 $187,385 - $250,442
-1,332 Reduced 0.58%
228,453 $37.1 Million
Q1 2022

May 13, 2022

BUY
$161.19 - $257.96 $1.79 Million - $2.87 Million
11,121 Added 5.09%
229,785 $43.2 Million
Q4 2021

Feb 09, 2022

SELL
$247.59 - $304.47 $163,656 - $201,254
-661 Reduced 0.3%
218,664 $57.9 Million
Q3 2021

Nov 12, 2021

SELL
$194.77 - $324.21 $5.03 Million - $8.37 Million
-25,822 Reduced 10.53%
219,325 $63.4 Million
Q2 2021

Aug 12, 2021

SELL
$165.87 - $220.95 $873,139 - $1.16 Million
-5,264 Reduced 2.1%
245,147 $48.9 Million
Q1 2021

May 14, 2021

SELL
$180.37 - $226.26 $8.03 Million - $10.1 Million
-44,497 Reduced 15.09%
250,411 $48.7 Million
Q4 2020

Feb 25, 2021

BUY
$148.08 - $206.57 $43.7 Million - $60.9 Million
294,908 New
294,908 $56.5 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.